Inventor · disambiguated record
Liping H. Pettus
Also filed as: PETTUS LIPING · PETTUS LIPING H
36 granted patents·19 pending applications·138 citations·filing 2003–2025
96Inventor score
Top patents by PatentIndex Score
55 records- 0193US7700593B2Imidazo- and triazolo-pyridine compounds and methods of use thereofAMGEN INC·Filed 2007·Granted Apr 20, 2010·35 cites·13 claims
- 0290US9090593B2Bicyclic compounds as Pim inhibitorsWANG HUI-LING·Filed 2011·Granted Jul 28, 2015·26 cites·51 claims
- 0389US12054476B2KIF18A inhibitorsAMGEN INC·Filed 2021·Granted Aug 6, 2024·1 cites·31 claims
- 0485US12509442B2KIF18A inhibitorsAMGEN INC·Filed 2024·Granted Dec 30, 2025·0 cites·32 claims
- 0584US11845760B2PRMT5 inhibitorsAMGEN INC·Filed 2021·Granted Dec 19, 2023·1 cites·46 claims
- 0684US7053088B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted May 30, 2006·19 cites·22 claims
- 0782US7759337B2Phthalazine compounds and methods of useAMGEN INC·Filed 2006·Granted Jul 20, 2010·7 cites·14 claims
- 0882US7396831B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jul 8, 2008·5 cites·21 claims
- 0982US7335672B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 26, 2008·6 cites·12 claims
- 1080US8772480B2Inhibitors of PI3 kinase and/or mTORAMGEN INC·Filed 2012·Granted Jul 8, 2014·5 cites·25 claims
- 1180US8367671B2Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agentsAMGEN INC·Filed 2009·Granted Feb 5, 2013·4 cites·12 claims
- 1279US8772481B2Aza- and diaza-phthalazine compounds as P38 map kinase modulators and methods of use thereofTASKER ANDREW·Filed 2009·Granted Jul 8, 2014·4 cites·13 claims
- 1379US8420649B2Pyrido[3,2-d]pyridazine-2(1H)-one compounds as p38 modulators and methods of use thereofPETTUS LIPING H·Filed 2009·Granted Apr 16, 2013·4 cites·12 claims
- 1478US8314131B2Triazole fused heteroaryl compounds and methods of use thereofPETTUS LIPING H·Filed 2008·Granted Nov 20, 2012·4 cites·17 claims
- 1578US7544803B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Jun 9, 2009·3 cites·4 claims
- 1677US7144888B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2003·Granted Dec 5, 2006·9 cites·25 claims
- 1776US2025304599A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2024·Application pending·0 cites
- 1875US12459932B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Nov 4, 2025·1 cites·34 claims
- 1972US7148221B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Dec 12, 2006·1 cites·19 claims
- 2071US7846944B2Pyrazolo-pyridinone compounds and methods of use thereofAMGEN INC·Filed 2008·Granted Dec 7, 2010·1 cites·18 claims
- 2169US9550762B2Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2015·Granted Jan 24, 2017·1 cites·95 claims
- 2269US9346801B2Substituted 7-oxo-pyrido[2,3-d]pyrimidines and methods of useAMGEN INC·Filed 2014·Granted May 24, 2016·1 cites·21 claims
- 2369US2025236631A1Macrocyclic compounds and methods of useAMGEN INC·Filed 2025·Application pending·0 cites
- 2469US2024092794A1Novel prmt5 inhibitorsAMGEN INC·Filed 2023·Application pending·0 cites
- 2559US2025163064A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 2658US8022085B2Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereofAMGEN INC·Filed 2008·Granted Sep 20, 2011·0 cites·16 claims
- 2758US2025179077A1Quinazoline compounds and uses thereof as inhibitors of mutant kras proteinsAMGEN INC·Filed 2023·Application pending·0 cites
- 2855US2025034167A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 2955US2025122222A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 3054US7524874B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Apr 28, 2009·0 cites·19 claims
- 3154US7332511B2Vanilloid receptor ligands and their use in treatmentsAMGEN INC·Filed 2005·Granted Feb 19, 2008·0 cites·19 claims
- 3254US2024124442A1Tricyclic-amido-bicyclic prmt5 inhibitorsAMGEN INC·Filed 2022·Application pending·0 cites
- 3354US2025059179A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 3454US2024417412A1Heterocyclic compounds and methods of useAMGEN INC·Filed 2022·Application pending·0 cites
- 3554US2025059205A1Heterocyclic Compounds and Methods of UseAMGEN INC·Filed 2022·Application pending·0 cites
- 3653US8080546B2Pyrazolo-pyridinone derivatives and methods of usePETTUS LIPING H·Filed 2008·Granted Dec 20, 2011·0 cites·15 claims
- 3752US8455495B2Pyridazino-pyridinone compounds and methods of usePETTUS LIPING H·Filed 2009·Granted Jun 4, 2013·0 cites·15 claims
- 3852US2023159510A1Novel prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 3952US2024101570A1Tricyclic carboxamide derivatives as prmt5 inhibitorsAMGEN INC·Filed 2021·Application pending·0 cites
- 4051US2022289724A1Kif18a inhibitorsAMGEN INC·Filed 2020·Application pending·0 cites
- 4148US12441705B2KIF18A inhibitorsAMGEN INC·Filed 2019·Granted Oct 14, 2025·0 cites·34 claims
- 4248US11548903B2Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jan 10, 2023·0 cites·29 claims
- 4347US8435987B2Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereofPETTUS LIPING H·Filed 2011·Granted May 7, 2013·0 cites·15 claims
- 4446US2017267673A1Cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2016·Application pending·0 cites
- 4545US11021493B21,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of useAMGEN INC·Filed 2017·Granted Jun 1, 2021·0 cites·33 claims
- 4643US8101612B2Phthalazine compounds and methods of useTASKER ANDREW·Filed 2007·Granted Jan 24, 2012·0 cites·10 claims
- 4742US9394297B2Amides as pim inhibitorsAMGEN INC·Filed 2013·Granted Jul 19, 2016·0 cites·20 claims
- 4842US2005165032A1Vanilloid receptor ligands and their use in treatmentsFiled 2005·Application pending·0 cites
- 4942US2007054916A1Aryl nitrogen-containing bicyclic compounds and methods of useAMGEN INC·Filed 2005·Application pending·0 cites
- 5042US2005165028A1Vanilloid receptor ligands and their use in treatmentsFiled 2005·Application pending·0 cites
Showing the top 50 of 55 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Liping H. Pettus files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →